Phlow
  • About
    • Who We Are
    • Our Impact
    • Leadership
    • Careers
  • CDMO
  • Product Portfolio
  • U.S. Facilities
    • Industrial Footprint
    • SAPIR™
  • News
  • Collaborate
Select Page

Pharma Venture Fuels $25M Expansion of AMPAC Facility in Petersburg

2021, Phlow™ in the News

Source: Richmond BizSense The pieces of a Petersburg pharmaceuticals hub continue to fall into place. AMPAC Fine Chemicals plans to invest $25 million and hire about 150 more employees at its Petersburg facility on North Normandy Drive to increase the pharmaceutical...

Pharmaceutical Ingredients Maker Plans $25 million Expansion at its Petersburg Plant, Adding 156 New Jobs

2021, Phlow™ in the News

Source: Richmond Times-Dispatch A manufacturer of pharmaceutical ingredients in Petersburg is planning a $25 million expansion of its operations that is expected to add 156 new jobs. AMPAC Fine Chemicals announced Tuesday the expansion plans for its plant on Normandy...

Governor Northam Announces AMPAC Fine Chemicals to Expand Petersburg Operation with $25 Million Investment, Adding 156 New Jobs

2021, Other News

Pharmaceutical manufacturer is a collaborator in new government-funded partnership to produce essential medications Source: Virginia Governor Ralph S. Northam PETERSBURG—Governor Ralph Northam today announced that AMPAC Fine Chemicals (AFC), a leading manufacturer of...

Leading Children’s Hospitals and Phlow Corp. Form an Unprecedented Coalition to Deliver Essential Medicines to Address Pediatric Drug Shortages

2021, Press Releases, Updates From Phlow™

RICHMOND, Va., March 18, 2021 – Phlow Corp., a U.S.-based, public benefit corporation committed to a bold mission of providing every American with access to affordable, high-quality essential medicines, today joins in announcing the launch of a groundbreaking...

Phlow Corp. and USP Announce Strategic Alliance Focused on Pharmaceutical Continuous Manufacturing to Increase Supply of Essential Medicines for U.S. Patients

2021, Press Releases, Updates From Phlow™

Source: BUSINESS WIRE RICHMOND, Va.– Phlow Corp., a public benefit essential medicines solutions provider, and the United States Pharmacopeia (USP) today announced a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical...
« Older Entries
Next Entries »

Recent Posts

  • Phlow Corp. Achieves Completion of Full-Scale Demonstration of Succinylcholine Chloride Active Pharmaceutical Ingredient (API) Production at its U.S. Metric Ton Facility
  • Phlow Corp. Expands Analytical Capabilities and Embraces Artificial Intelligence-Driven System, Ushering in a New Era of Modern Medicine Manufacturing in America
  • Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America
  • JPEO-CBRND, in Partnership with HHS, Utilizes Interagency Agreement to Contract with Phlow Corporation to Provide Medical Countermeasures
  • Phlow Observes 4th Annual National Essential Medicine Shortage Awareness Day, Reaffirms Commitment to Protecting America’s Medicine Cabinet

Recent Comments

No comments to show.

WHY THIS MATTERS
JOIN US

+1 (804) 207-4893

[email protected]

424 Hull St., Suite 400
Richmond, VA 23224

MEDIA INQUIRIES

STAY CONNECTED

  • Follow
  • Follow
  • Follow

To report an adverse event or product complaint associated with Phlow Drug Products, please call (844) 708-2982.

Privacy Policy | Consent Preferences | Additional Resources & Policies